Moreover, correlation between cMET expression and HGF rescue in vemurafenib-treated BRAF-mutant melanoma cells was not high in this study (r2 = 0.56) suggesting that cMET contribution to microenvironment-mediated BRAF-inhibitor resistance remains to be clarified. The gene discussed is HGF; the disease is melanoma.